Literature DB >> 25661319

Inhibition of cathepsin L sensitizes human glioma cells to ionizing radiation in vitro through NF-κB signaling pathway.

Neng Yang1, Pan Wang1, Wen-juan Wang1, Yun-zhen Song1, Zhong-qin Liang1.   

Abstract

AIM: Cathepsin L, a lysosomal cysteine proteinase, is exclusively elevated in a variety of malignancies, including gliomas. In this study we investigated the relationship between cathepsin L and NF-κB, two radiation-responsive elements, in regulating the sensitivity of human glioma cells ionizing radiation (IR) in vitro.
METHODS: Human glioma U251 cells were exposed to IR (10 Gy), and the expression of cathepsin L and NF-κB was measured using Western blotting. The nuclear translocation of NF-κB p65 and p50 was analyzed with immunofluorescence assays. Cell apoptosis was examined with clonogenic assays. NF-κB transcription and NF-κB-dependent cyclin D1 and ATM transactivation were monitored using luciferase reporter and ChIP assays, respectively. DNA damage repair was investigated using the comet assay.
RESULTS: IR significantly increased expression of cathepsin L and NF-κB p65 and p50 in the cells. Furthermore, IR significantly increased the nuclear translocation of NF-κB, and NF-κB-dependent cyclin D1 and ATM transactivation in the cells. Knockdown of p65 did not change the expression of cathepsin L in IR-treated cells. Pretreatment with Z-FY-CHO (a selective cathepsin L inhibitor), or knockdown of cathepsin L significantly attenuated IR-induced nuclear translocation of NF-κB and cyclin D1 and ATM transactivation, and sensitized the cells to IR. Pretreatment with Z-FY-CHO, or knockdown of p65 also decreased IR-induced DNA damage repair and clonogenic cell survival, and sensitized the cells to IR.
CONCLUSION: Cathepsin L acts as an upstream regulator of NF-κB activation in human glioma cells and contributes to their sensitivity to IR in vitro. Inhibition of cathepsin L can sensitize the cells to IR.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25661319      PMCID: PMC4349927          DOI: 10.1038/aps.2014.148

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  40 in total

1.  TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.

Authors:  C Y Wang; M W Mayo; A S Baldwin
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

2.  Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells.

Authors:  N Yamagishi; J Miyakoshi; H Takebe
Journal:  Int J Radiat Biol       Date:  1997-08       Impact factor: 2.694

3.  The role of [beta]-transducin repeat-containing protein ([beta]-TrCP) in the regulation of NF-[kappa]B in vascular smooth muscle cells.

Authors:  Xiaohong Wang; Neeta Adhikari; Qinglu Li; Zhanjun Guan; Jennifer L Hall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-30       Impact factor: 8.311

Review 4.  Complete and limited proteolysis in cell cycle progression.

Authors:  Brigitte Goulet; Alain Nepveu
Journal:  Cell Cycle       Date:  2004-08-16       Impact factor: 4.534

Review 5.  Proteases in brain tumour progression.

Authors:  N Levicar; R K Nuttall; T T Lah; R K Nutall
Journal:  Acta Neurochir (Wien)       Date:  2003-09       Impact factor: 2.216

Review 6.  NF-kappaB in mammary gland development and breast cancer.

Authors:  Yixue Cao; Michael Karin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

7.  Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades.

Authors:  Masuko Katoh; Masaru Katoh
Journal:  Int J Mol Med       Date:  2009-06       Impact factor: 4.101

8.  Ionizing radiation induces expression and binding activity of the nuclear factor kappa B.

Authors:  M A Brach; R Hass; M L Sherman; H Gunji; R Weichselbaum; D Kufe
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

Review 9.  Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review).

Authors:  J Kos; T T Lah
Journal:  Oncol Rep       Date:  1998 Nov-Dec       Impact factor: 3.906

10.  Cathepsin L plays a role in quinolinic acid-induced NF-Κb activation and excitotoxicity in rat striatal neurons.

Authors:  Yan-Ru Wang; Shu Qin; Rong Han; Jun-Chao Wu; Zhong-Qin Liang; Zheng-Hong Qin; Yan Wang
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

View more
  4 in total

1.  Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells.

Authors:  Mei-Ling Han; Yi-Fan Zhao; Cai-Hong Tan; Ya-Jie Xiong; Wen-Juan Wang; Feng Wu; Yao Fei; Long Wang; Zhong-Qin Liang
Journal:  Acta Pharmacol Sin       Date:  2016-11-14       Impact factor: 6.150

Review 2.  Role of lysosomes in physiological activities, diseases, and therapy.

Authors:  Ziqi Zhang; Pengfei Yue; Tianqi Lu; Yang Wang; Yuquan Wei; Xiawei Wei
Journal:  J Hematol Oncol       Date:  2021-05-14       Impact factor: 17.388

3.  HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells.

Authors:  Yanyan Zhang; Zhi Xu; Jiaji Ding; Chunli Tan; Weizi Hu; Yunman Li; Wenlong Huang; Yong Xu
Journal:  J Exp Clin Cancer Res       Date:  2018-07-27

4.  LncRNA MATN1-AS1 prevents glioblastoma cell from proliferation and invasion via RELA regulation and MAPK signaling pathway.

Authors:  Na Han; Li Yang; Xiaoxi Zhang; Yangmei Zhou; Rui Chen; Yang Yu; Zhen Dong; Mengxian Zhang
Journal:  Ann Transl Med       Date:  2019-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.